Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity

British Journal of Haematology

Volumn 105, Issue 1, 1999, Pages 163-172

  Dotti, Gianpietro ^a   Garattini, Enrico ^a,d   Borleri, Gianmaria ^a   Masuhara, Kensaku ^a,b   Spinelli, Orietta ^a   Barbui, Tiziano ^c   Rambaldi, Alessandro ^a,b  

^a Ospedali Riuniti di Bergamo   (Japan)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

Chronic myelogenous leukaemia; G CSF; Granulocyte differentiation; Leucocyte alkaline phosphatase; Tyrosine kinase activity

Indexed keywords

ALKALINE PHOSPHATASE; CD11B ANTIGEN; PROTEIN TYROSINE KINASE;

ARTICLE; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; CELL TRANSFORMATION, NEOPLASTIC; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTES; MACROPHAGE-1 ANTIGEN; NEUTROPHILS; PROTEIN-TYROSINE KINASES; RECEPTORS, IGG; RNA, MESSENGER;

EID: 0032951034     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1999.01299.x     Document Type: Article

References (37)

1. Bedi, A. , Zehnbauer, B. A. , Barber, J. P. , Sharkis, S. J. & Jones, R. J. (1994) Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood, 83, 2038-2044.
2. Borregaard, N. , Kjeldsen, L, Rygaard, K. , Bastholm, L. , Nielsen, M. H. , Sangelov, HBjerrum, O. W. & Johnsen, A. H. (1992) Stimulus-dependent secretion of plasma proteins from human neutrophils. Journal of Clinical Investigation, 90, 86-96.
3. Borregaard, N. , Miller. L. J. & Springer. T. A. (1987) Chemoattractant-regulated mobilisation of novel intracellular compartment in human neutrophils. Science, 237, 1204-1206.
4. Carlo-Stella, C. , Dotti, G. , Mangoni, L. , Regazzi, E. , Garau. D. , Bonati, A. , Almici, C. , Sammarelli, G. , Savoldo, B. , Rizzo, M. T. & Rizzoli, V. (1996) Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with tyrosine kinase inhibitor genistein. Blood, 88, 3091-3100.
5. Colotta. F. , Re, E, Polentarutti, NSozzani, S. & Mantovani. A. (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood, 80, 2012-2020.
6. Cordell, J. LFalini. B. , Fjrber, W. N. , Ghosh, A. K. , Abdulaziz, Z. , MacDonald, S. , Pulford, K. A. , Stein. H. & Mason, D. Y. (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase anti alkaline phosphatase (APAAP complex). Journal of llistochemistry and Cytochemistry. 32, 219-229.
7. bcr-abl protein. Proceedings of the National Academy of Sciences of the United States of America, 85, 9312-9316.
8. de Haas. MKerst, J. Mvan der School, C. E. , Calafat, J. , Hack. C. E. , Nuijens. J. H. , Roos, D. ,' van Oers, R. H. J. & von dem Borne. A. E. G. Kr. (1994) Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood, 84, 3885-3894.
9. De Renzo, A. , Micera, V. , Vaglio. S. , Luciano, L, Seilen, C. & Rotoli. B. (1990) Induction of alkaline phosphatase activity in chronic myeloid leukemia cells: in vitro studies and speculative hypotheses American Journal o]'Hematology, 35, 278-280.
10. Druker, B. J. , Tamura, S. , Buchdunger, E. , Ohno, S. , Segal. G. MFanning, S. , Zimmermann, J. & Lydon, N. B. (1996) Effects of selective inhibitor of the Abl tyrosine kinase on the growth of BcrAbl positive cells. Nature Medicine, 2, 561-566.
11. Gianni, M. , Terao, M. , Zanotta, S. , Barbui, T. , Rambaldi, A. & Garattini, E. (1994) Retinoic acid and granulocyte colonystimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia. Blood, 83, 1909-1921.
12. Garattini, E. & Gianni, M. (1996) Leukocyte alkaline phosphatase a specific marker for post-mitotic neutrophilic granulocyte: regulation in acute promyelocytic leukemia. Leukemia and lymphoma, 23, 493-503.
13. Garattini, E, Hua, JC & Udenfriend, S. (1987) Cloning and sequencing of bovine kidney alkaline phosphatase cDNA. Gene, 59. 41-46.
14. Gordon, M. Y. , Dowding, C. R. , Riley, G. P. , Goldman, J. M. & Greaves, M. F. (1987) Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature, 328, 342-344.
15. Hayhoe, F. G. J. & Quaglino, D. (1958) Cytochemical demonstration and measurement of leucocyte phosphatase activity in normal and pathological states by modified azo-dye coupling techniques. British Journal of Haematology. 4, 375-389.
16. Homburg. C. H. E. , de Haas, M. , von dem Borne, A. E. G. Kr Verhoeven. A. JReutelingsperger, C. P. M. & Rpos, D. (1995) Human neutrophils lose their surface FcyRIII and acquire annexin V binding sites during apoptosis in vitro. Blood, 85. 532-540.
17. Huizinga, T. Wvan der School. C. E. , Jost, C. , Klaassen, R. , Kleijer, M. , von dem Borne. A. ERoos. D. & Tetteroo, P. A. (1988) The PI-linked receptor FcRIII is released on Stimulation of neutrophils. Nature. 333, 667-669.
18. Kawakami, M. , Tsutsumi, IL, Kumakawa, T. , Abe, H. , Hirai, M. , Kurosawa. SMori, M. & Fukushima, M. (1990) Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood. 76. 1962-1964.
19. Kerst. J. Mdc Haas, M. , van der School. C. ESlaper-Cortenbach. I. C. MKleijer, M. , von dem Borne, A. E. G. Kr. & van Oers R. H. J. (1993) Recombinant granulocyte colony-stimulaling faclor adminislralion lo healthy volunlcers: induclion of immunophenolypically and funclionally allered neutrophils via an effect on myeloid progenitor cells. Blood. 82, 3265-3272.
20. Konopka, J. BWatanabe. S. M. & Witte, O. K. (1984) An alteration of Ihe human c-abl prolein in K562 leukaemia cells unmasks associaled tyroslne kinase activity. Cell. 37. 1035-1042.
21. Kurzrock. RGutterman, J. U. & Talpaz. M. (1988) The molecular genelics of Philadelphia chromosome-posilive leukemia. New England Journal of Medicine. 319, 990-998.
22. Masuda. Y. , Kizaki, M. , Ueno, H. , Mori, S. , Takayama, N. , Muto. A. , Matsushita, IL, Ikeda. E. , Kawai, Y. & Ikeda, Y. (1995) Chronic myelogenous leukemia (CML) associated with granulocyte colonystimulating factor (G-CSF)-producing mesothelioma. leukemia, 9, 1591-1611.
23. Minty. A. J. , Caravatti, M. , Robert, B. , Cohen, A. , Daubas. PWeydert, A. , Gros, F. & Buckingham. M. E. (1981) Mouse actin messenger RNAs construction and characterisation of a recombinant plasmid molecule containing a complementary DNA transcript of mouse a-actin mRNA. Journal of Biological themistry. 256, 1008-1014. '
24. Morstyn, GCampbell, L. , Lieschke, G. , Layton, J. E. , Mäher, DO'Connor, M. , Green. M. , Sheridan, WVincent, M. , Alton, K. , Souza, L. McGrath. K. & Fox. R. M. (1989) Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimisation of dose and duration of therapy. Journal of Clinical Oncology. 7, 1554-1562.
25. Pedersen, B. (1982) Functional and biochemical phenotype in relation to cellular age of differentiated neutrophils in chronic myeloid leukaemia. British Journal of Haemalology. 51. 339-344.
26. Peeillie, P. E. (1967) Studies of the changes in leukocyte alkaline phosphatase following pyrogen stimulation in chronic granulocytic leukemia. Blood, 29. 401-406.
27. Rambaldi, A. , Masuhara, K. , Borleri, G. M. , Amaru, R. , Gianni, M. , Terao. M. , Barbui, T. & Garattini, E. (1997) Flow cytomctry of leucocyte alkaline phosphatase in normal and pathologic leucocytes. British Journal of Ilaematology. 96, 815-822.
28. Rambaldi, A. , Terao. M,. Bettoni. SBassan, R. , Battista, R. , Barbui, T. & Garattini. E. (1989) Difference in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes. Blood. 73, 1113-1115.
29. Rambaldi, ATerao, M. , Bettoni, S. , Tini, M. L. , Bassan. RBarbui, T. & Garattini, E. (1990) Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: regulation of the transcript by granulocyte colony-stimulating factor. Blood, 76, 2565-2571.
30. Rambaldi, A. , Viero, P. , Bassan. R. , Buelli, M. , Rossi. A. , Bellavita, P. , Spinelli, 0. , Amaru. RMicheletti, M. , Borleri. G. , Cortelazzo, S. , Comotti. B. & Barbui T. (1996) G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemias. Leukemia, 10, 869-865.
31. Salgia, R. , Li, J-L. , Ewaniuk, D. SPear, VV. , Pisick, E. , Burky, S. A. , Ernst, T, Sattler, M. , Chen, LB. & Griffin, J. D. (1997) BCR/ABL induces multiple abnormalities of cytoskeletal function. Journal of Clinical Investigation, 100, 46-57.
32. Sato, R, Mizukami, H. , Tani, K. & Asano, S. (1991) Regulation of mRNA levels of alkaline phosphatase gene in neutrophilic granulocytes by colony-stimulating factor and retinoic acid. European Journal of Haematology. 46, 107-111.
33. Sato. NMori, M. , Oshimura, M. , Ueyama, Y. , Mhva, T. , Ohsawa. NKosaka. K. & Asano, S. (1982) Factor(s) responsible for the increase in alkaline phosphatase activity of post-mitotic granulocytes from normal individuals and patients with chronic myeloid leukemia. Blood, 59, 142-147.
34. Stewart, C. A. (1974) Leukocyte alkaline phosphatase in myeloid maturation. Pathology. 6, 287-293.
35. Terstappen. L. W. M. M. , Safford, M. & Loken, M. R. (1990) Flow cylometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia, 4. 657-663.
36. Watari. K. , Asano, SShirafuji. N. , Kodo, H. , Ozawa, K. , Takaku. F. & Kamachi, S-i. (1989) Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood, 73, 117-122.
37. Yuo. A. , Kitagawa, S. , Okabe, T, Urabe, A. , Komatsu, Y. , Itoh, S. & Takaku, F. (1987) Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndrome and chronic myelogenous leukemia. Blood, 70, 404-411.